Dendritic Cell-based Immune Therapy: Concept, Design, Present Limitations, and Future Projections



Immune therapy seems to be a rational therapeutic choice for treating patients with immune-mediated anomalies. In some diseases, immune-related factors are primarily responsible for disease pathogenesis. Autoimmune diseases are a typical example. In addition, an immune-mediated phenomenon is related to rejection of organ transplants. Thus, immune therapy may be used for treating autoimmune diseases. Rejection of transplanted organs may be delayed or blocked by immune intervention strategies.


Protective Immunity Immune Tolerance Immune Therapy Vaccine Therapy Chronic Viral Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Recommended Readings

  1. Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296–306CrossRefPubMedGoogle Scholar
  2. Fazle Akbar SM, Abe M, Yoshida O, Murakami H, Onji M (2006) Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes. Curr Med Chem 13:3113–3119PubMedCrossRefGoogle Scholar
  3. Figdor CG, De Vries IJ, Lesterhuis WJ, Melief CJ (2006) Dendritic cell immunotherapy: mapping the way. Nat Med 10:475–480CrossRefGoogle Scholar
  4. Mocellin S (2005) Cancer vaccines: the challenge of developing an ideal tumor killing system. Front Biosci 10:2285–2305CrossRefPubMedGoogle Scholar
  5. Slingluff CL Jr, Engelhard VH, Ferrone S (2006) Peptide and dendritic cell vaccines. Clin Cancer Res 12:2342s–2345sCrossRefPubMedGoogle Scholar
  6. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature (Lond) 449:419–426CrossRefGoogle Scholar
  7. Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A (2007) Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother 56:1513–1537CrossRefPubMedGoogle Scholar

Copyright information

© Morikazu Onji and Sk. Md. Fazle Akbar 2008

Personalised recommendations